genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
GEN Edge
Cytiva Picks Up Where GE Leaves Off after $21B Deal
Artificial Intelligence
Putting COVID-19 on the ‘Map’
GEN Edge
Athersys Stem Cell Therapy Targets Top Cause of COVID-19 Deaths
GEN Edge
Cellectis’ New Patent Supports CRISPR-Based T-Cell Immunotherapies
GEN Edge
Top 15 Best-Selling Drugs of 2019
News
News
Artificial Proteins Give Living Cells a Computational Upgrade
Artificial Intelligence
GSK Invests $250M in Vir as Companies Partner on COVID-19 Candidates
News
J&J’s Janssen, Fate Therapeutics Launch Up-to-$3B Cancer Immunotherapy Collaboration
Coronavirus
Possible SARS-CoV-2 Vulnerability Revealed by Human Antibody
Coronavirus
Anti-Parasitic Drug Halts Coronavirus Replication in Lab-Grown Cells within 48 Hours
Insights
All
Trends for 2020
Commentary
Understanding Glycans in COVID-19 Drug Design
Coronavirus
NYC Scientists Swab the Subway in Search of SARS-CoV-2
Artificial Intelligence
Artificial Intelligence Is Helping Biotech Get Real
April 2020 Vol. 40 No.4
Cell-Based Immunotherapies Do Battle With Solid Tumors
A-Lists
Gilead Sciences
Catching Up to Coronavirus: Top 60 Treatments in Development
GEN Edge
Top 15 Best-Selling Drugs of 2019
Coronavirus
How to Conquer Coronavirus: Top 35 Treatments in Development
Insights
Top 10 Life Sciences Jobs Most in Demand over the Next…
GEN Edge
Ten Life Science Analysts to Watch in 2020
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Artificial Proteins Give Living Cells a Computational Upgrade
Artificial Intelligence
GSK Invests $250M in Vir as Companies Partner on COVID-19 Candidates
News
J&J’s Janssen, Fate Therapeutics Launch Up-to-$3B Cancer Immunotherapy Collaboration
Coronavirus
Anti-Parasitic Drug Halts Coronavirus Replication in Lab-Grown Cells within 48 Hours
Magazine
March 2020 Vol. 40 No. 3
Expanding the CRISPR Toolbox
Commentary
Strategies for Optimizing CRISPR-Cas9 Delivery into Hard-to-Transfect Cells
March 2020 Vol. 40 No. 3
RNA Silencing Finds Its Therapeutic Voice
March 2020 Vol. 40 No. 3
Genomic Medicine Identifies Reconcilable Differences
Commentary
Hasten Genomic Medicine’s Rise with Advanced Data Management
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Upcoming Webinars
Feel the Flow: Immune Cell Signaling Cascades Reveal Phenotype and Function
April 2020 Vol. 40 No.4
A New Lease on Life for shRNA
April 2020 Vol. 40 No.4
To Improve Protein Aggregation Assessments, Combine PCT and MMS
April 2020 Vol. 40 No.4
Protein Labeling Kit
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Rare and Neglected Diseases
Rare and Neglected Diseases
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Rare and Neglected Diseases
Trial Triumphs, Takeover Talk Boost Reata Pharmaceuticals
Rare and Neglected Diseases
Gene Therapy Developer Passage Bio Files for $125M IPO
Rare and Neglected Diseases
Sangamo CEO Looks Long-Term toward In Vivo Genome Editing, Regulation
Rare and Neglected Diseases
AGTC Plans Pivotal Trial for XLRP Gene Therapy
Rare and Neglected Diseases
AGTC Grows Preclinical Pipeline with Gene Therapies for Congenital Hearing Loss, Stargardt Disease
Rare and Neglected Diseases
Dicerna, Novo Nordisk Eye 30+ Liver Targets in Up-to-$3.8B RNAi Partnership
Rare and Neglected Diseases
Celgene, Acceleron Win FDA OK for Drug to Treat Anemia in...
Rare and Neglected Diseases
FDA Places Partial Clinical Hold on Some Trials of Novartis Gene...
Rare and Neglected Diseases
Schistosome Parasite Paralyzed by Chemical Produced by Tiny Aquatic Animal
Rare and Neglected Diseases
Alexion to Acquire Achillion for $930M+, Expanding Rare Disease Portfolio
Rare and Neglected Diseases
UCB to Acquire Ra Pharma for $2.1B, Raising Rare Disease Presence
Rare and Neglected Diseases
Lonza, Prevail Therapeutics Partner on Gene Therapy Manufacturing
Rare and Neglected Diseases
Deep Genomics Identifies AI-Discovered Candidate for Wilson Disease
Rare and Neglected Diseases
Passage Bio Licenses Gene Therapy Candidate for CMT2A from Penn, Days...
Rare and Neglected Diseases
Sumitomo Dainippon Commits $3B toward Alliance with Roivant
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
